L-Deprenyl does not reduce brain damage in global forebrain ischemia in adult gerbils (Meriones ungiculatus). (Q48722721)

15 February 2018

title

L-Deprenyl does not reduce brain damage in global forebrain ischemia in adult gerbils (Meriones ungiculatus). (English)

1 reference

15 February 2018

0 references

Ballabriga J

1

1 reference

15 February 2018

Pellisé A

series ordinal

2

1 reference

15 February 2018

Ferrer I

series ordinal

3

1 reference

15 February 2018

publication date

1 May 1997

1 reference

15 February 2018

Journal of the Neurological Sciences

published in

1 reference

15 February 2018

volume

148

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

1-5

1 reference

15 February 2018

Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

The free radical hypothesis in idiopathic parkinsonism: evidence against it

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Sequential changes in activities of superoxide dismutase and catalase in brain regions and liver during (-)deprenyl infusion in male rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

(-)Deprenyl increases activities of superoxide dismutase and catalase in striatum but not in hippocampus: the sex and age-related differences in the optimal dose in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Evidence of nuclear DNA fragmentation following hypoxia-ischemia in the infant rat brain, and transient forebrain ischemia in the adult gerbil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Resistance of hippocampal CA-1 interneurons to 20 min of transient cerebral ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Delayed neuronal death in the gerbil hippocampus following ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Selective vulnerability in the gerbil hippocampus following transient ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Delayed neuronal death in the rat hippocampus following transient forebrain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

L-deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Clinical neuromythology IX. Pyramid sale in the bucket shop: DATATOP bottoms out

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Effects of a MAO-B inhibitor in the treatment of Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Selegiline as initial treatment in de novo parkinsonian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Delayed neuronal recovery and neuronal death in rat hippocampus following severe cerebral ischemia: possible relationship to abnormalities in neuronal processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Sequential development of reversible and irreversible neuronal damage following cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Deprenyl reduces the death of motoneurons caused by axotomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Selective vulnerability of the hippocampus in brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Cognitive effects of L-deprenyl in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Effect of deprenyl on the progression of disability in early Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischaemia: a qualitative and quantitative sequential study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Pharmacological actions of l-deprenyl (selegiline) and other selective monoamine oxidase B inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

Pharmacokinetic aspects of l-deprenyl (selegiline) and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

inferred from DOI database lookup

7 January 2021

based on heuristic

The pharmacology of selegiline ((-)deprenyl). New aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2896%2905306-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(96)05306-3

1 reference

15 February 2018

1 reference

15 February 2018